Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Classical Microscopy Outperforms Automated Urine Analysis

By LabMedica International staff writers
Posted on 07 May 2014
The human eye using a microscope can be more accurate than automation when it comes to analyzing urine samples for signs of kidney damage. More...


An automated urine analysis system can miss signs of kidney damage that can easily be identified by a trained observer looking through a compound microscope at the urine sample.

A team of scientists at the University of Arizona (Phoenix, AZ, USA) investigated how well each approach, microscopy and automated analysis, was able to identify granular and muddy brown casts, tiny tube-like structures made of protein secreted by the kidney. Casts in the setting of kidney damage can help identify the underlying problem such as inflammation or infection, and counting them and identifying their characteristics and composition can provide important diagnostic and prognostic information.

Each of the 10 samples analyzed were from patients with acute kidney injury. A single person analyzed each urine sample, first by examining it under the microscope, and then with the automated IRIS 200 urinary analysis system (Iris Diagnostics; Chatsworth, CA, USA). The IRIS 200 system coded 70% of the samples as having no casts. All of the samples were classified as having few casts using manual microscopy. The samples that were automatically coded on IRIS 200 as having many casts were also coded as few by manual microscopy.

Natasha Sharda, MD, the lead investigator, said, “The automated system underreported the value of granular casts in our patient cohort of acute kidney injury. The automated system still has utility as a screening test, but manual microscopy should be done in all cases of abnormal kidney function, as accurate quantification of casts could have some prognostic benefit to patients. Even though the automated urinalysis system has many benefits, it should not replace direct observation, but rather be used as augmentation.”

Thomas Manley, director of scientific activities at the National Kidney Foundation (New York, NY, USA) added, “Technological advances in medicine have been extremely valuable in improving outcomes for patients, but in some cases the human eye is still superior to machines. In this study manual microscopy was superior to an automated urinalysis in evaluating urine sediment properties.” The study was presented at the National Kidney Foundation's 2014 Spring Clinical Meetings held April 22–26, 2014, in Las Vegas (NV, USA).

Related Links:

University of Arizona
Iris Diagnostics
National Kidney Foundation



New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated MALDI-TOF MS System
EXS 3000
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.